Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECTOPIA: Catheter Ablation vs Anti-arrhythmic Drugs for VPB
NCT03845010Completed
- Sponsor
- Cardiologie Zwolle
- Start
- Feb 2019
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Cardiologie Zwolle. Primary endpoint: Successful therapy at 3 months. Started Feb 2019; status: completed.
Beyond the preview
Go deeper on NCT03845010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03845010.